Modality-specific peripheral antinociceptive effects of μ-opioid agonists on heat and mechanical stimuli: Contribution of sigma-1 receptors

[1]  J. Entrena,et al.  Grip strength in mice with joint inflammation: A rheumatology function test sensitive to pain and analgesia , 2017, Neuropharmacology.

[2]  J. Penninger,et al.  Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice , 2017, Proceedings of the National Academy of Sciences.

[3]  J. Entrena,et al.  Sigma-1 Receptor Antagonists: A New Class of Neuromodulatory Analgesics. , 2017, Advances in experimental medicine and biology.

[4]  B. Davletov,et al.  Sigma-1 receptor expression in the dorsal root ganglion: Reexamination using a highly specific antibody , 2016, Neuroscience.

[5]  M. Rodríguez-Muñoz,et al.  The ON:OFF switch, σ1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: Implications in neurological disorders , 2015, Oncotarget.

[6]  W. Hou,et al.  The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence , 2015, Channels.

[7]  J. Vela,et al.  The σ1 Receptor Engages the Redox-Regulated HINT1 Protein to Bring Opioid Analgesia Under NMDA Receptor Negative Control , 2015, Antioxidants & redox signaling.

[8]  David P. Roberson,et al.  Transcriptional profiling at whole population and single cell levels reveals somatosensory neuron molecular diversity , 2014, eLife.

[9]  A. Basbaum,et al.  Delta Opioid Receptors Presynaptically Regulate Cutaneous Mechanosensory Neuron Input to the Spinal Cord Dorsal Horn , 2014, Neuron.

[10]  J. Entrena,et al.  Modulation of Peripheral μ-Opioid Analgesia by σ1 Receptors , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[11]  S. A. Bura,et al.  Sigma-1 receptor antagonism as opioid adjuvant strategy: enhancement of opioid antinociception without increasing adverse effects. , 2013, European journal of pharmacology.

[12]  D. Zamanillo,et al.  Potentiation of morphine-induced mechanical antinociception by σ1 receptor inhibition: Role of peripheral σ1 receptors , 2013, Neuropharmacology.

[13]  D. J. Cavanaugh,et al.  The modality‐specific contribution of peptidergic and non‐peptidergic nociceptors is manifest at the level of dorsal horn nociresponsive neurons , 2013, The Journal of physiology.

[14]  J. Entrena,et al.  Highlighted Papers Modulation of Peripheral m-Opioid Analgesia by s 1 Receptors , 2013 .

[15]  D. Zamanillo,et al.  Pharmacological properties of S1RA, a new sigma‐1 receptor antagonist that inhibits neuropathic pain and activity‐induced spinal sensitization , 2012, British journal of pharmacology.

[16]  S. Mousa,et al.  Relative contributions of peripheral versus supraspinal or spinal opioid receptors to the antinociception of systemic opioids , 2012, European journal of pain.

[17]  S. Hsieh,et al.  P2X3-mediated peripheral sensitization of neuropathic pain in resiniferatoxin-induced neuropathy , 2012, Experimental Neurology.

[18]  R. Al-Hasani,et al.  Molecular mechanisms of opioid receptor-dependent signaling and behavior. , 2011, Anesthesiology.

[19]  G. Pasternak,et al.  Mu opioid receptors in pain management. , 2011, Acta anaesthesiologica Taiwanica : official journal of the Taiwan Society of Anesthesiologists.

[20]  S. Mishra,et al.  Ablation of TrpV1 neurons reveals their selective role in thermal pain sensation , 2010, Molecular and Cellular Neuroscience.

[21]  A. Basbaum,et al.  Dissociation of the Opioid Receptor Mechanisms that Control Mechanical and Heat Pain , 2009, Cell.

[22]  David J Anderson,et al.  Distinct subsets of unmyelinated primary sensory fibers mediate behavioral responses to noxious thermal and mechanical stimuli , 2009, Proceedings of the National Academy of Sciences.

[23]  J. Entrena,et al.  Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors , 2009, Psychopharmacology.

[24]  J. Priestley.  Neuropeptides: Sensory Systems , 2009 .

[25]  K. Standifer,et al.  Methylnaltrexone in the treatment of opioid-induced constipation , 2008, Clinical and experimental gastroenterology.

[26]  J. Entrena,et al.  Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands , 2008, Current neuropharmacology.

[27]  A. Beitz,et al.  Intrathecal Injection of the &sfgr;1 Receptor Antagonist BD1047 Blocks Both Mechanical Allodynia and Increases in Spinal NR1 Expression during the Induction Phase of Rodent Neuropathic Pain , 2008, Anesthesiology.

[28]  D. Chappell,et al.  Methylnaltrexone for opioid-induced constipation in advanced illness. , 2008, The New England journal of medicine.

[29]  S. Hsieh,et al.  Enhancement of Cutaneous Nerve Regeneration by 4-Methylcatechol in Resiniferatoxin-Induced Neuropathy , 2008, Journal of neuropathology and experimental neurology.

[30]  N. Stambler,et al.  Methylnaltrexone for opioid-induced constipation in advanced illness. , 2008, The New England journal of medicine.

[31]  G. Pasternak,et al.  Modulation of Brainstem Opiate Analgesia in the Rat by σ1 Receptors: A Microinjection Study , 2007, Journal of Pharmacology and Experimental Therapeutics.

[32]  C. Parenti,et al.  In vivo evaluation of (+)-MR200 as a new selective sigma ligand modulating MOP, DOP and KOP supraspinal analgesia. , 2006, Life sciences.

[33]  Eva García,et al.  Analgesic effects of capsazepine and resiniferatoxin on bone cancer pain in mice , 2006, Neuroscience Letters.

[34]  M. Danhof,et al.  Pharmacokinetic-Pharmacodynamic Modeling of the Antinociceptive Effect of Buprenorphine and Fentanyl in Rats: Role of Receptor Equilibration Kinetics , 2005, Journal of Pharmacology and Experimental Therapeutics.

[35]  Á. Meana,et al.  Analgesic effects of loperamide in bone cancer pain in mice , 2005, Pharmacology Biochemistry and Behavior.

[36]  David J. Anderson,et al.  Topographically Distinct Epidermal Nociceptive Circuits Revealed by Axonal Tracers Targeted to Mrgprd , 2005, Neuron.

[37]  L. Sumanovski,et al.  Mu-Opiate Receptor and Beta-Endorphin Expression in Nerve Endings and Keratinocytes in Human Skin , 2004, Dermatology.

[38]  M. Caterina,et al.  Nociceptors Lacking TRPV1 and TRPV2 Have Normal Heat Responses , 2004, The Journal of Neuroscience.

[39]  Teruo Hayashi,et al.  σ-1 Receptor Ligands , 2004 .

[40]  Teruo Hayashi,et al.  Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders. , 2004, CNS drugs.

[41]  M. Kress,et al.  The inflammatory mediators serotonin, prostaglandin e2 and bradykinin evoke calcium influx in rat sensory neurons , 2003, Neuroscience.

[42]  J. D. Richardson,et al.  Cellular Mechanisms of Neurogenic Inflammation , 2002, Journal of Pharmacology and Experimental Therapeutics.

[43]  G. Gebhart,et al.  Chronic pain and medullary descending facilitation , 2002, Trends in Neurosciences.

[44]  J. Simpson,et al.  Glial Cell Line-Derived Neurotrophic Factor is a Survival Factor for Isolectin B4-Positive, but not Vanilloid Receptor 1-Positive, Neurons in the Mouse , 2002, The Journal of Neuroscience.

[45]  G. Pasternak,et al.  Sigma1 receptor modulation of opioid analgesia in the mouse. , 2002, The Journal of pharmacology and experimental therapeutics.

[46]  A. Lastra,et al.  Unilateral hot plate test: a simple and sensitive method for detecting central and peripheral hyperalgesia in mice , 2002, Journal of Neuroscience Methods.

[47]  R. Quirion,et al.  Expression of the purported sigma1 (σ1) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy , 2000, Journal of Chemical Neuroanatomy.

[48]  I. Guillemain,et al.  Immunocytochemical localization of the sigma1 receptor in the adult rat central nervous system , 2000, Neuroscience.

[49]  G. Pasternak,et al.  Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist. , 1999, The Journal of pharmacology and experimental therapeutics.

[50]  R. Sittl,et al.  Peripheral antihyperalgesic effect of morphine to heat, but not mechanical, stimulation in healthy volunteers after ultraviolet-B irradiation. , 1999, Anesthesia and analgesia.

[51]  G. Pasternak,et al.  Cloning and Characterization of a Mouse σ1 Receptor , 1998 .

[52]  T Pietsch,et al.  NeuN: a useful neuronal marker for diagnostic histopathology. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[53]  G. M. Smith,et al.  Cloning and Characterization of a Bovine P2Y Receptor , 1995 .

[54]  G. Pasternak,et al.  Sigma antagonists potentiate opioid analgesia in rats , 1995, Neuroscience Letters.

[55]  G. Pasternak,et al.  Selective antagonism of opioid analgesia by a sigma system. , 1994, The Journal of pharmacology and experimental therapeutics.

[56]  R. J. Mullen,et al.  NeuN, a neuronal specific nuclear protein in vertebrates. , 1992, Development.